Related Tags

Tags: uk + marijuana.with.MS

Sort by: Date / Title / URL

  1. Savitex, an oral spray developed by the drugs company GW Pharmaceuticals, is now unlikely to gain regulatory approval in this country until 2009 despite recently winning full regulatory approval in Canada
  2. European Journal of Neurology (EJN) reports a study1 which shows that Sativex, a cannabis based medicine, significantly reduces intractable spasms and stiffness (spasticity) in people with Multiple Sclerosis
  3. Three people who supplied chocolate bars laced with cannabis to multiple sclerosis sufferers walked free from court yesterday.
  4. People with multiple sclerosis are backing a Norfolk and Norwich University Hospital study into whether cannabis will help them cope with the condition.
  5. A couple who gave thousands of chocolate bars laced with cannabis to multiple sclerosis patients for pain relief were found guilty yesterday of conspiring to supply the drug.
  6. Cash receipts totalling £30,000 were seized from the home of a couple who supplied chocolate bars laced with cannabis to multiple sclerosis sufferers, a court heard today.
  7. GW pharmaceuticals is developing a portfolio of cannabis medicines the first of which, Sativex, received an Approval with Conditions from Health Canada in April 2005 for use as an adjunctive treatment for the symptom relief of neuropathic pain in MS
  8. Information on sativex: news, experiences and updates
  9. THC4MS aims to supply medicinal cannabis chocolate information to bone-fide MS sufferers i.e. As a first point of contact.
  10. Prosecutors are taking a firm line on the supply of cannabis for pain relief to people with chronically painful conditions such as multiple sclerosis, despite the downgrading of the drug from class B to class C.
  11. Clinicians from across the UK have now embarked on the world's first trial to investigate whether cannabis derivatives could play a role in slowing the progression of multiple sclerosis.
  12. A GRANDMOTHER suffering from multiple sclerosis faces forking out more than £2,000 a year for a painkilling cannabis-based drug after NHS chiefs refused to fund it.
    10-07-2006 to , , , by admin

First / Previous / Next / Last / Page 1 of 1